InterventionsIn silico

Eligibility, Impact, and Costs for Tirzepatide for the Primary Prevention of Diabetes Mellitus

ADA Scientific Sessions 2025 Abstract

The paper

LUSK JB, AYMES S, OBRIEN E et al.

ADA Scientific Sessions 2025 Abstract · 21 Jun 2025

Presented at ADA Scientific Sessions 2025 · Oral 173-OR

doi.org/10.2337/db25-173-or

Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026